QT Sense Company Profile

Background

Overview

QT Sense B.V., established in February 2024, is a pioneering quantum sensing technology company based in Groningen, Netherlands. The company specializes in utilizing nanodiamond-based quantum sensing to detect cellular activity at the single-cell level, focusing on oxidative stress and its implications in various health conditions. QT Sense's flagship product, Quantum Nuova, is a single-cell Nano-MRI platform designed to provide real-time, non-invasive insights into cellular processes.

Mission and Vision

QT Sense is dedicated to advancing biomedical research by offering precise, real-time measurements of free radicals within living cells. This approach aims to enhance early disease detection, improve personalized treatment strategies, and accelerate drug development processes. By leveraging quantum sensing technologies, QT Sense seeks to transform our understanding of cellular dynamics and their role in health and disease.

Industry Significance

The company's innovative use of quantum sensing positions it at the forefront of biomedical diagnostics and research. By enabling single-cell analysis of oxidative stress, QT Sense addresses a critical need in the medical field for more accurate and early detection methods, particularly in complex diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions.

Key Strategic Focus

Core Objectives

Advancement of Quantum Sensing Technologies: Develop and refine quantum sensing tools to provide high-resolution, real-time data on cellular activity.

Disease Diagnostics and Research: Utilize quantum sensing to enhance the understanding of disease mechanisms, enabling early detection and personalized treatment approaches.

Drug Development Support: Offer insights into oxidative stress pathways to aid in the development of targeted therapies and improve drug efficacy assessments.

Areas of Specialization

Single-Cell Analysis: Employ nanodiamond-based quantum sensing for detailed examination of individual cells.

Oxidative Stress Measurement: Focus on detecting free radicals to study their role in various health conditions.

Biomedical Research Tools: Provide advanced platforms for researchers in academia and the pharmaceutical industry.

Key Technologies Utilized

Quantum Sensing with Nanodiamonds: Utilize nitrogen-vacancy (NV) centers in diamonds to perform quantum measurements, enabling detection of magnetic field variations caused by free radicals.

T1 Relaxometry: Apply this technique to measure the relaxation times of NV centers, providing insights into oxidative stress levels within cells.

Primary Markets Targeted

Academic and Translational Research: Equip researchers with tools for studying cellular mechanisms and disease processes.

Pharmaceutical and Biotechnology Industries: Support drug development and toxicity screening through detailed cellular analysis.

Healthcare and Life Sciences: Enhance diagnostic capabilities and personalized medicine approaches.

Financials and Funding

Funding History

In February 2025, QT Sense secured €6 million in funding to advance its Quantum Nuova product. The investment comprised equity from quantum-focused venture capital firm QDNL Participations, angel investors, and grant funding from Interreg Europe.

Utilization of Capital

The funds are allocated towards refining the Quantum Nuova platform, supporting product development, and facilitating its deployment at the University Medical Center Groningen for sepsis diagnostics research.

Pipeline Development

Key Pipeline Candidates

Quantum Nuova: A single-cell Nano-MRI platform designed to measure cellular activity with high precision, enabling early sepsis diagnostics and personalized cancer treatment.

Stages of Development

Product Refinement: Ongoing development to enhance the platform's capabilities and performance.

Clinical Deployment: Preparation for deployment at the University Medical Center Groningen for sepsis diagnostics research.

Target Conditions

Sepsis: Early detection and monitoring of oxidative stress related to sepsis.

Cancer: Personalized treatment strategies through understanding tumor-related oxidative stress.

Anticipated Milestones

Clinical Implementation: Initiation of clinical studies at partner institutions.

Product Launch: Commercial availability of Quantum Nuova for broader applications.

Technological Platform and Innovation

Proprietary Technologies

Nanodiamond-Based Quantum Sensing: Utilize NV centers in diamonds for high-resolution, real-time detection of free radicals within live cells.

Significant Scientific Methods

T1 Relaxometry: Measure relaxation times of NV centers to assess oxidative stress levels.

Confocal Microscopy Integration: Combine quantum sensing with confocal microscopy for precise localization of nanodiamonds within cells.

AI-Driven Capabilities

Data Analytics: Employ advanced data processing algorithms to interpret complex cellular data and provide actionable insights.

Leadership Team

Deepak H. Veeregowda: Co-founder and CEO with 15 years of experience in engineering and entrepreneurship, leading the strategic direction of QT Sense.

Prof. Dr. Romana Schirhagl: Co-founder and Chief Scientific Officer, a leading expert in quantum sensing at the single-cell level, overseeing scientific research and development.

Hoang Nguyen: Chief Operating Officer with over a decade of experience in finance, investments, and operations, managing the company's operational strategies.

Competitor Profile

Market Insights and Dynamics

The biomedical diagnostics market is experiencing significant growth, driven by advancements in precision medicine and the increasing prevalence of chronic diseases. Technologies enabling single-cell analysis and real-time monitoring are in high demand, presenting opportunities for companies like QT Sense to lead in this niche.

Competitor Analysis

QT Sense operates in a specialized segment of the biomedical diagnostics market, focusing on quantum sensing for single-cell analysis. While there are other companies in the broader quantum sensing and biomedical diagnostics fields, QT Sense's unique approach and technology position it distinctively in the market.

Strategic Collaborations and Partnerships

QT Sense has established a significant partnership with the University Medical Center Groningen, focusing on early sepsis detection. This collaboration facilitates the clinical application of Quantum Nuova and supports ongoing research initiatives.

Operational Insights

QT Sense differentiates itself through its proprietary nanodiamond-based quantum sensing technology, offering non-invasive, real-time, and subcellular insights into cellular processes. This capability provides a competitive edge in the biomedical diagnostics market, particularly in areas requiring high-resolution cellular analysis.

Strategic Opportunities and Future Directions

QT Sense aims to expand its product offerings by developing additional quantum sensing tools for various biomedical applications. The company plans to enhance its technology platform, explore new market segments, and establish further strategic partnerships to drive growth and innovation.